{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:17:03Z","timestamp":1788581823545,"version":"build-2803163510"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152677","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T19:53:58Z","timestamp":1459886038000},"page":"e0152677","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation"],"prefix":"10.1371","volume":"11","author":[{"given":"S M D K Ganga","family":"Senarathna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Page-Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"ref1","article-title":"Guidelines for the treatment of malaria","year":"2010"},{"issue":"15","key":"ref2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMra043207","article-title":"Effectiveness of antimalarial drugs","volume":"352","author":"JK Baird","year":"2005","journal-title":"N Engl J Med"},{"issue":"8311","key":"ref3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(82)91532-X","article-title":"Type II mefloquine resistance in Thailand","volume":"320","author":"E Boudreau","year":"1982","journal-title":"Lancet"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"AM Dondorp","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0169-409X(02)00171-0","article-title":"Drug\u2014drug interaction mediated by inhibition and induction of P-glycoprotein","volume":"55","author":"JH Lin","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0925-4439(96)00008-7","article-title":"Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein","volume":"1316","author":"S Ayesh","year":"1996","journal-title":"BBA-Mol Basis Dis"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","article-title":"The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin","volume":"104","author":"B Greiner","year":"1999","journal-title":"J Clin Invest"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/infdis\/jit078","article-title":"Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants","volume":"207","author":"DJ Creek","year":"2013","journal-title":"J Infect Dis"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1086\/511882","article-title":"Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz","volume":"44","author":"P German","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref10","unstructured":"Gasasira AF. Interactions between HIV infection and malaria in children living in sub-Saharan Africa in the era of widening access to improved interventions [Ph.D. Thesis]: UC Berkeley; 2010."},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4269\/ajtmh.1998.59.519","article-title":"Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice","volume":"59","author":"A Nontprasert","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","article-title":"Artemisinin: mechanisms of action, resistance and toxicity","volume":"32","author":"SR Meshnick","year":"2002","journal-title":"Int J Parasitol"},{"issue":"13","key":"ref13","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/ange.200503071","article-title":"Artemisone\u2014a highly active antimalarial drug of the artemisinin class","volume":"118","author":"RK Haynes","year":"2006","journal-title":"Angew Chem Int Ed"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkl563","article-title":"Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo","volume":"59","author":"L Vivas","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005318","article-title":"Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial","volume":"4","author":"B Coulibaly","year":"2009","journal-title":"PLoS ONE"},{"key":"ref16","unstructured":"Food and Drug Administration. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. Guidance for Industry. Rockville U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research (CDER); 2015."},{"issue":"1","key":"ref17","first-page":"27","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"P Artursson","year":"1996","journal-title":"Adv Drug Deliv Rev"},{"key":"ref18","first-page":"103","article-title":"Correlation between paracellular and transcellular drug permeability in the human jejunum and Caco-2 monolayers","volume":"127","author":"H Lennern\u00e4s","year":"1996","journal-title":"Int J Pharm"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10611860600720814","article-title":"Limited P-glycoprotein mediated efflux for anti-epileptic drugs","volume":"14","author":"A Crowe","year":"2006","journal-title":"J Drug Target"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0169-409X(96)00416-4","article-title":"The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development","volume":"22","author":"CA Bailey","year":"1996","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1023\/A:1016005212640","article-title":"Age-dependent expression of P-glycoprotein gp17O in Caco-2 cell monolayers","volume":"13","author":"K-I Hosoya","year":"1996","journal-title":"Pharm Res"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1081\/DDC-120037471","article-title":"pH dependent uptake of loperamide across the gastrointestinal tract: an in vitro study","volume":"30","author":"A Crowe","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"ref23","first-page":"798","article-title":"The influence of passage number for Caco2 cell models when evaluating P-gp mediated drug transport","volume":"70","author":"S Senarathna","year":"2015","journal-title":"Die Pharmazie"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.taap.2012.03.008","article-title":"Oral and inhaled corticosteroids: differences in P-glycoprotein (ABCB1) mediated efflux","volume":"260","author":"A Crowe","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","article-title":"Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells","volume":"79","author":"P Artursson","year":"1990","journal-title":"J Pharm Sci"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (CACO-2) cells","volume":"175","author":"P Artursson","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1023\/A:1011940108365","article-title":"In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin","volume":"15","author":"A Crowe","year":"1998","journal-title":"Pharma Res"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/mp050071a","article-title":"Computational models for identifying potential P-glycoprotein substrates and inhibitors","volume":"3","author":"P Crivori","year":"2006","journal-title":"Mol Pharm"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/AAC.01253-06","article-title":"Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers","volume":"51","author":"TM Davis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-4347(00)83258-2","article-title":"Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography","volume":"374","author":"E Pussard","year":"1986","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002280000124","article-title":"Pharmacokinetics and organ distribution of intravenous and oral methylene blue","volume":"56","author":"C Peter","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/AAC.06232-11","article-title":"Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria","volume":"56","author":"S Salman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1128\/AAC.00375-11","article-title":"Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether","volume":"55","author":"L Manning","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5\u20136","key":"ref34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00755788","article-title":"Differentiated intestinal epithelial cell lines asin vitro models for predicting the intestinal absorption of drugs","volume":"10","author":"P Wils","year":"1994","journal-title":"Cell Biol Toxicol"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0006-2952(96)00556-4","article-title":"Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine","volume":"52","author":"CD Riffkin","year":"1996","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002800050468","article-title":"Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing","volume":"38","author":"L-B Lan","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2\u20133","key":"ref37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0304-4165(00)00160-4","article-title":"Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT","volume":"1524","author":"YT Pham","year":"2000","journal-title":"BBA-Gen Subjects"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4269\/ajtmh.2012.11-0817","article-title":"Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells","volume":"87","author":"E Oga","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref39","year":"2010","unstructured":"Scholtz JC. Preparation, stability and in vitro evaluation of liposomes containing amodiaquine\/Jacques C. Scholtz [M.Sc. Thesis]. Potchefstroom: North-West University; <year>2010<\/year>."},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2006.05.009","article-title":"The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux","volume":"29","author":"R Hayeshi","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1248\/bpb.25.1555","article-title":"Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562\/adr and GLC4\/adr resistant cell lines","volume":"25","author":"P Reungpatthanaphong","year":"2002","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-200427010-00003","article-title":"Antimalarial drug toxicity","volume":"27","author":"WRJ Taylor","year":"2004","journal-title":"Drug Saf"},{"issue":"1","key":"ref43","first-page":"83","article-title":"Pharmacokinetics of mefloquine alone or in combination with artesunate","volume":"72","author":"J Karbwang","year":"1994","journal-title":"Bull World Health Organ"},{"issue":"31","key":"ref44","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.chroma.2011.05.102","article-title":"Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space","volume":"1218","author":"B Debrus","year":"2011","journal-title":"J Chromatogr A"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1002\/jps.23312","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: Amodiaquine hydrochloride","volume":"101","author":"A Nair","year":"2012","journal-title":"J Pharm Sci"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.1987.tb03002.x","article-title":"The disposition of amodiaquine in man after oral administration","volume":"23","author":"P Winstanley","year":"1987","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1983.tb01532.x","article-title":"Disposition of chloroquine in man after single intravenous and oral doses","volume":"15","author":"L Gustafsson","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"ref48","unstructured":"European Medicines Agency. Assessment report Methylthioninium chloride Proveblue [02.12.2014]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002108\/WC500107131.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002108\/WC500107131.pdf<\/ext-link>."},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1039\/b205786g","article-title":"Kinetics and mechanism of a fast leuco-Methylene Blue oxidation by copper (II)\u2013halide species in acidic aqueous media","author":"O Impert","year":"2003","journal-title":"Dalton Trans"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00228-008-0563-x","article-title":"High absolute bioavailability of methylene blue given as an aqueous oral formulation","volume":"65","author":"I Walter-Sack","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"ref51","article-title":"Malaria","author":"W Peters","year":"1975"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1475-2875-4-45","article-title":"Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]","volume":"4","author":"PE Meissner","year":"2005","journal-title":"Malar J"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1021\/js960001i","article-title":"Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells","volume":"85","author":"P Augustijns","year":"1996","journal-title":"J Pharm Sci"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.2042-7158.1996.tb05870.x","article-title":"Chemical stability of artesunate injection and proposal for its administration by intravenous infusion","volume":"48","author":"KT Batty","year":"1996","journal-title":"J Pharm Pharmacol"},{"issue":"1\u20132","key":"ref55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/DMR-120001389","article-title":"Drugs as P-glycoprotein substrates, inhibitors, and inducers","volume":"34","author":"RB Kim","year":"2002","journal-title":"Drug metab Rev"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"AH Schinkel","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/mol.104.009019","article-title":"Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor","volume":"67","author":"O Burk","year":"2005","journal-title":"Mol pharmacol"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0928-0987(00)00077-4","article-title":"Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics","volume":"10","author":"T \u00d6sterberg","year":"2000","journal-title":"Eur J Pharm Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:01:20Z","timestamp":1588964480000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152677"}},"subtitle":[],"editor":[{"given":"M\u00e1ria A.","family":"Deli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152677","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}